F2G
F2G is advancing its own patented compounds and technologies which will lead to the development of novel agents to treat serious fungal disease. The Company was founded on its proprietary genomics technology (MycoBank®) that identifies essential gene targets in fungi. Having received initial funding in 2002 the company then rapidly diversified into chemistry-driven discovery. They have also assembled an experienced development capacity.
F2G
Industry:
Biotechnology Genetics Health Care Medical Pharmaceutical
Founded:
1998-01-01
Address:
Manchester, Manchester, United Kingdom
Country:
United Kingdom
Website Url:
http://www.f2g.com
Total Employee:
251+
Status:
Active
Contact:
44 (0)161 785 1270
Email Addresses:
[email protected]
Total Funding:
283.32 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apache Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Aprea
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Aptahem
Aptahem develops aptamer-based drugs for the treatment of acute life-threatening conditions
Aptarion biotech
Aptarion biotech is a developer Biostable L-Aptamers for the treatment Of Life-Threatening diseases And for Biosensors.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Forendo Pharma
Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases.
GenSight Biologics
GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.
Insilico Medicine
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
ISCA Diagnostics
ISCA Diagnostics is specialising in point-of-care tests for life-threatening fungal infections of humans.
LYSOGENE
Lysogene is a pioneer in the basic research and clinical development of gene therapy for neurodegenerative disorders.
Methuselah Health
Methuselah Health identifies novel targets for treatment of ageing-related diseases.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
RespiVert
Respivert is a small molecule drug discovery company for the treatment of chronic obstructive pulmonary diseases.
Travere Therapeutics
Travere discovers and develops drugs for the treatment of catastrophic diseases that are debilitating and often life-threatening.
SkinJect
SkinJect develops a novel drug delivery system for the treatment of non-melanoma skin cancers.
Smart Cells
Smart Cells provides stored stem cell units for use in the treatment of children with life-threatening illnesses.
TopoTarget UK Limited
TopoTarget UK Limited is discovers and develops drugs for the treatment of proliferative diseases.
Vical
Vical develops biopharmaceutical drugs to prevent and treat chronic or life-threatening infectious diseases.
ZS Pharma
ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Forbion Capital Partners
Forbion Capital Partners investment in Private Equity Round - F2G
Sofinnova Partners
Sofinnova Partners investment in Private Equity Round - F2G
Brace Pharma
Brace Pharma investment in Private Equity Round - F2G
Morningside Venture Investments
Morningside Venture Investments investment in Private Equity Round - F2G
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Private Equity Round - F2G
Novo Ventures
Novo Ventures investment in Private Equity Round - F2G
Advent Life Sciences
Advent Life Sciences investment in Private Equity Round - F2G
European Investment Bank
European Investment Bank investment in Debt Financing - F2G
Sectoral Asset Management
Sectoral Asset Management investment in Private Equity Round - F2G
Aisling Capital
Aisling Capital investment in Private Equity Round - F2G
Official Site Inspections
http://www.f2g.com Semrush global rank: 9.53 M Semrush visits lastest month: 141
- Host name: f2gcorp.tempurl.host
- IP address: 136.244.82.232
- Location: Frankfurt am Main Germany
- Latitude: 50.1103
- Longitude: 8.7147
- Timezone: Europe/Berlin
- Postal: 60314
